Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Manufacturing

Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus

 April 23, 2026

BioPharma Dive

The 185-acre site will be the company s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.

ManufacturingRead full story

Post navigation

Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs →
← CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com